103 related articles for article (PubMed ID: 22189954)
1. Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticals.
Straub JO; Gysel D; Kastl U; Klemmer J; Sonderegger M; Studer M
Environ Toxicol Chem; 2012 Mar; 31(3):681-7. PubMed ID: 22189954
[TBL] [Abstract][Full Text] [Related]
2. Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnology.
Straub JO; Shearer R; Studer M
Environ Toxicol Chem; 2014 Sep; 33(9):2140-6. PubMed ID: 24917475
[TBL] [Abstract][Full Text] [Related]
3. Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.
Straub JO; Oldenkamp R; Pfister T; Häner A
Environ Toxicol Chem; 2019 Oct; 38(10):2259-2278. PubMed ID: 31225916
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
Liebig M; Moltmann JF; Knacker T
Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
[TBL] [Abstract][Full Text] [Related]
5. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
6. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
Gros M; Petrović M; Ginebreda A; Barceló D
Environ Int; 2010 Jan; 36(1):15-26. PubMed ID: 19819553
[TBL] [Abstract][Full Text] [Related]
7. Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania.
Moldovan Z; Chira R; Alder AC
Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S46-54. PubMed ID: 18972147
[TBL] [Abstract][Full Text] [Related]
8. Environmental risk assessment for the galenical formulation of solid medicinal products at Roche Basle, Switzerland.
Hoerger CC; Dörr B; Schlienger C; Straubt JO
Integr Environ Assess Manag; 2009 Apr; 5(2):331-7. PubMed ID: 19061300
[TBL] [Abstract][Full Text] [Related]
9. Identification of relevant micropollutants in Austrian municipal wastewater and their behaviour during wastewater treatment.
Clara M; Windhofer G; Weilgony P; Gans O; Denner M; Chovanec A; Zessner M
Chemosphere; 2012 Jun; 87(11):1265-72. PubMed ID: 22342340
[TBL] [Abstract][Full Text] [Related]
10. Triclosan: its occurrence, fate and effects in the Australian environment.
Kookana RS; Ying GG; Waller NJ
Water Sci Technol; 2011; 63(4):598-604. PubMed ID: 21330702
[TBL] [Abstract][Full Text] [Related]
11. Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe.
Straub JO
Environ Toxicol Chem; 2016 Apr; 35(4):767-79. PubMed ID: 25693841
[TBL] [Abstract][Full Text] [Related]
12. Prospective environmental risk assessment of mixtures in wastewater treatment plant effluents - Theoretical considerations and experimental verification.
Coors A; Vollmar P; Sacher F; Polleichtner C; Hassold E; Gildemeister D; Kühnen U
Water Res; 2018 Sep; 140():56-66. PubMed ID: 29684702
[TBL] [Abstract][Full Text] [Related]
13. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
[TBL] [Abstract][Full Text] [Related]
14. Drug residues in urban water: A database for ecotoxicological risk management.
Destrieux D; Laurent F; Budzinski H; Pedelucq J; Vervier P; Gerino M
Sci Total Environ; 2017 Dec; 609():927-941. PubMed ID: 28783905
[TBL] [Abstract][Full Text] [Related]
15. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?
Ferrari B; Mons R; Vollat B; Fraysse B; Paxéus N; Lo Giudice R; Pollio A; Garric J
Environ Toxicol Chem; 2004 May; 23(5):1344-54. PubMed ID: 15180389
[TBL] [Abstract][Full Text] [Related]
16. Environmental hazard and risk assessment of thiochemicals. Application of integrated testing and intelligent assessment strategies (ITS) to fulfil the REACH requirements for aquatic toxicity.
Ahlers J; Nendza M; Schwartz D
Chemosphere; 2019 Jan; 214():480-490. PubMed ID: 30278402
[TBL] [Abstract][Full Text] [Related]
17. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
18. A new risk assessment approach for the prioritization of 500 classical and emerging organic microcontaminants as potential river basin specific pollutants under the European Water Framework Directive.
von der Ohe PC; Dulio V; Slobodnik J; De Deckere E; Kühne R; Ebert RU; Ginebreda A; De Cooman W; Schüürmann G; Brack W
Sci Total Environ; 2011 May; 409(11):2064-77. PubMed ID: 21414651
[TBL] [Abstract][Full Text] [Related]
19. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
[TBL] [Abstract][Full Text] [Related]
20. Substance flow analysis as a tool for mitigating the impact of pharmaceuticals on the aquatic system.
Chèvre N; Coutu S; Margot J; Wynn HK; Bader HP; Scheidegger R; Rossi L
Water Res; 2013 Jun; 47(9):2995-3005. PubMed ID: 23561493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
